TRDA

Entrada Therapeutics, Inc.

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: SanBio Co (OtherSNBIF), Oruka Therapeutics (ORKA) and Entrada Therapeutics Inc (TRDA)

• TipRanks·4d ago

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• NASDAQ·4d ago

  Noteworthy Thursday Option Activity: TRDA, JBS, MCRI

• Benzinga·6d ago

  What's Going On With Entrada Therapeutics Stock Wednesday?

• NASDAQ·6d ago

  Entrada Therapeutics Advances Duchenne Study To Highest Planned Dose Level

• TipRanks·6d ago

  Entrada Therapeutics reports positive ENTR-601-45 trial results

• NASDAQ·6d ago

  Entrada Reports Positive Topline Data From Cohort 1 Of Phase 1/2 ELEVATE-45-201 Study Of ENTR-601-45

• TipRanks·6d ago

  Entrada Therapeutics reports data from Cohort 1 of ELEVATE-45-201 clinical study

• Benzinga·6d ago

  Entrada Therapeutics Announces Independent Data Monitoring Committee Review Of All Available Safety And PK Data From The Eight Participants Enrolled In Cohort 2 Of The Double-Blind, Placebo-Controlled, Multiple Ascending Dose Portion of ELEVATE-44-201

• Seeking Alpha·10/10 06:47

  Entrada Therapeutics: Weak Dystrophin Data May Be Creating A Buying Opportunity

• TipRanks·09/10 02:01

  Major Investors Quietly Unload a Big Chunk of Entrada Therapeutics Shares

• TipRanks·09/04 02:03

  Major Investors Quietly Unload a Big Chunk of Entrada Therapeutics Stock

• TipRanks·09/03 11:30

  Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)

• TipRanks·08/17 08:59

  Entrada Therapeutics price target raised to $11 from $10 at Roth Capital

• TipRanks·08/12 19:10

  Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Entrada Therapeutics Inc (TRDA)